Navigation Links
Bio-Optronics Incorporates RxPaying(TM) Patient Stipend Debit Card Feature in Clinical Conductor(TM) Clinical Trial Management System (CTMS)
Date:4/21/2009

ROCHESTER, N.Y., April 21 /PRNewswire/ -- Bio-Optronics, Inc. will enhance its Clinical Conductor(TM) Clinical Trial Management System with click-through integration to Interspond's RxPaying(TM) debit card solution. This offers a patient stipend payment alternative which improves efficiency and increases patient satisfaction. Clinical Conductor(TM) CTMS provides natural points in clinical trial workflow into which best-in-class tools and expertise can be integrated seamlessly. Dan Kerpelman, President and CEO states, "We are pleased to be integrating RxPaying(TM) debit cards as an efficient alternative to the patient stipend payment process and will continue to leverage Clinical Conductor(TM) as the entry point for seamless integration to tools that optimize efficiency, productivity, and improve collaboration across the clinical environment."

Clinical Conductor(TM) CTMS, proven to improve site efficiency and productivity, handles the complete enterprise workflow, from business development, to patient databases, recruitment, scheduling, workload planning, finances, and complete oversight and reporting, and provides an innovative Electronic Data Capture option. The academic medical center clinical trial management system solution adds research administration capabilities and custom interfaces to hospital enterprise systems.

The Rx Paying(TM) Debit Card helps ensure higher patient participation and retention by providing immediate access to their funds, which can be used to purchase items, request cash back from a purchase or get cash from an ATM. It centralizes the process of patient reimbursement for clinical studies as a whole. "Integrating RxPaying(TM) with Clinical Conductor(TM), one of the leading CTMS in the industry, is a natural fit and we are excited about our partnership. While both products are excellent stand-alone systems, the integration creates a more dynamic product by eliminating redundancy and streamlining the reimbursement process," according to Kathy S. Cox, President & CEO of Interspond.

Bio-Optronics, Inc. develops, deploys, and operates software products and custom information technology solutions to help healthcare professionals manage and optimize workflow, thus enhancing quality, productivity, and patient and staff satisfaction. For over 20 years, Bio-Optronics has demonstrated leadership in innovation, expertise in workflow and integration, and a singular approach to unparalleled customer service. Our workflow solutions are used in over 30 Veterans' Administration and other hospitals in the U.S., and over 400 clinical research sites around the world. www.bio-optronics.com

Interspond is a Trial Management Organization (TMO) for the pharmaceutical and biotechnology industries working to identify study opportunities for sites' participation. We maintain a database of hundreds of qualified, experienced investigative sites capable of conducting Phase I through Phase IV studies. These sites are located throughout the country and are multi-therapeutic in nature. Our RxPaying(TM) service offers electronic reimbursement for the clinical research industry. RxPaying(TM) streamlines and simplifies the process of reimbursing patients for participation in clinical research studies through the use of an instant issue debit card. www.interspond.com

CONTACT: Bio-Optronics, (877) 279-8377, www.bio-optronics.com; Maria Durkin, VP, Director Marketing and Operations, mdurkin@bio-optronics.com


'/>"/>
SOURCE Bio-Optronics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Health Management Corporation Incorporates Clinically Proven Care Diabetes Management Program With Programming From dLife
2. ASA plus clopidogrel reduces heart attack risk in patients with acute coronary syndrome
3. First Patients in United States Receive Innovative Device to Treat Moderate Heart Failure
4. Surveyed Specialists Foresee Greater Use of Parenteral Outpatient Therapy for the Treatment of Osteomyelitis
5. WakeMed Shares Best Practices for Tracking Assets, Patients
6. Tragic choices: Is it better for doctors or patient families to decide?
7. Thomson Reuters Study Finds More Patients Postponing Medical Care Due to Cost
8. Genetic variants predict recurrence of bladder cancer, patient survival
9. Acupuncture eases radiation-induced dry mouth in cancer patients
10. Doctor-Patient Talks Key to Blacks Getting Cancer Screens
11. PatientCentral Technologies, LLC and VerdaSee Solutions, Inc. Team Up With Congressional Staff in Washington, DC for Disaster Preparedness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... ... January 23, 2017 , ... During the ... Carol Francis, Psychologist in the South Bay area , explained “Watching Women’s ... all people and by all people shines as a bright beacon of determination ...
(Date:1/24/2017)... ... , ... The National Council of Alcoholism and Drug Dependence ( NCADD ), ... communities to designate the last full week of January as National Drug and Alcohol ... Myths.” As a community, we can advocate for effective treatment, but also especially ...
(Date:1/23/2017)... New York, NY (PRWEB) , ... January 23, 2017 , ... ... firm, announced today that John J. Nelson, a senior accountant at the Firm, will ... behalf of Make-A-Wish® Hudson Valley. Over 200 runners will race up 1,576 steps, a ...
(Date:1/23/2017)... , ... January 23, 2017 , ... ... educational institution’s inaugural K-20 Education Summit to be held March 23-25, 2017 in ... by Jan. 25, 2017. , The keynote speakers include Dr. Michelle R. Weise, ...
(Date:1/23/2017)... ... 23, 2017 , ... The iaedp Foundation, recognized for its ... who treat the full spectrum of eating disorder problems, proudly announces the addition ... of the leading eating disorder treatments centers located throughout the U.S. As partners ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... The global peripheral I.V. catheter market accounted ... expected to grow at a CAGR of 6.0% during ... larger share in the global market between the two ... the hospital segment accounted for the highest share in ... peripheral I.V. catheter market is witnessing high growth rate, ...
(Date:1/23/2017)... Calif. , Jan. 23, 2017  HOPE ... exclusive rights to develop and commercialize nuc ... Therapeutics, a Korean pharmaceutical company. ... DNA aptamer against surface nucleolin found on many ... gemcitabine. Unlike ADCs (antibody drug conjugates) or SMDCs ...
(Date:1/23/2017)... Calif. , Jan. 23, 2017  Based ... market, Frost & Sullivan recognizes Ansell, a global ... Frost & Sullivan Company of the Year Award. ... approach, and a wide global footprint have placed ... the hand protection market. The Company,s established product ...
Breaking Medicine Technology: